Cash Flow Lee's Pharmaceutical Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
74.00
98.00
31.00
68.00
1,972.00
145.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
56.00
-53.00
-76.00
-15.00
40.00
-87.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
335.00
241.00
113.00
286.00
189.00
210.00
Cash Flow from Investing Activities
-238.00
-192.00
-146.00
-258.00
-372.00
-499.00
Cash Flow from Financing Activities
35.00
-1.00
13.00
-128.00
60.00
-41.00
Net Cash Inflow / Outflow
128.00
47.00
-19.00
-88.00
-121.00
-334.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-4.00
0.00
0.00
12.00
0.00
-3.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Lee's Pharmaceutical Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
74.733
-259.342073640901
333.00
128.82%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
56.372
61.9826796835395
-5.00
-9.05%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
335.601
-128.12559101717
463.00
361.93%
Cash Flow from Investing Activities
-238.462
107.226825663346
-345.00
-322.39%
Cash Flow from Financing Activities
35.583
5.15148601093247
30.00
590.73%
Net Cash Inflow / Outflow
128.603
-16.6441801704801
144.00
872.66%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-4.119
-0.896900827587611
-4.00
-359.25%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 38.69% vs 112.60% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
335.60
241.98
38.69%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
